These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9881659

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet.
    Imai T, Kawasaki C, Nishiyama T, Otagiri M.
    Pharmazie; 2000 Mar; 55(3):218-22. PubMed ID: 10756544
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
    van Steeg TJ, Krekels EH, Freijer J, Danhof M, de Lange EC.
    J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
    [Abstract] [Full Text] [Related]

  • 25. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
    Murai-Kushiya M, Okada S, Kimura T, Hasegawa R.
    J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Harron DW, Goa KL, Langtry HD.
    Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
    [Abstract] [Full Text] [Related]

  • 32. The bioavailability of two beta-blockers preadsorbed onto charcoal.
    Roivas L, Ojala-Karlsson P, Neuvonen PJ.
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):125-32. PubMed ID: 7911863
    [Abstract] [Full Text] [Related]

  • 33. Bioequivalence of two oral immediate release formulations of pindolol in healthy volunteers assessed by ratio analysis.
    Koch HJ, Raschka C, Hannak D.
    Acta Physiol Pharmacol Bulg; 2000 Mar; 25(3-4):99-102. PubMed ID: 11688554
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A, Honbo A, Iga K.
    Int J Pharm; 2008 Feb 12; 349(1-2):53-60. PubMed ID: 17765415
    [Abstract] [Full Text] [Related]

  • 36. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE, Hamilton TC, Robson D.
    Br J Pharmacol; 1977 Jul 12; 60(3):461-9. PubMed ID: 19118
    [Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G, Regàrdh CG.
    Clin Pharmacokinet; 1976 Jul 12; 1(4):233-63. PubMed ID: 13958
    [Abstract] [Full Text] [Related]

  • 38. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T, Chin WP, Yoshida Y, Sun HT, Mitomi A, Ishibashi T, Tamura K, Imai S.
    Arch Int Pharmacodyn Ther; 1989 Jul 12; 302():145-57. PubMed ID: 2576891
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.